Gene · 11034
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MET fusions are targetable genomic variants in the treatment of advanced malignancies. | Cell Commun Signal | 2024 | 38195556 | PubTator, text mining | PubMed |
| Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma. | Biochem Biophys Rep | 2024 | 38188362 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38180745 | PubTator, text mining | PubMed |
| EEG Microstates as a Signature of Hemispheric Lateralization in Stroke. | Brain Topogr | 2024 | 37195492 | PubTator, text mining | PubMed |
| Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. | Front Immunol | 2023 | 38235128 | PubTator, text mining | PubMed |
| Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment. | Front Endocrinol (Lausanne) | 2023 | 38116315 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. | Sci Rep | 2023 | 38097783 | PubTator, text mining | PubMed |
| Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles. | Int J Mol Sci | 2023 | 38069306 | PubTator, text mining | PubMed |
| Pricing of Shanghai stock exchange 50 ETF options based on different volatility models. | PLoS One | 2023 | 38060470 | PubTator, text mining | PubMed |
| Molecular characteristics of circulating B cells and kidney cells at the single-cell level in special types of primary membranous nephropathy. | Clin Kidney J | 2023 | 38046035 | PubTator, text mining | PubMed |
| Muscle cofilin alters neuromuscular junction postsynaptic development to strengthen functional neurotransmission. | bioRxiv | 2023 | 38045306 | PubTator, text mining | PubMed |
| Research progress on the roles of actin-depolymerizing factor in plant stress responses. | Front Plant Sci | 2023 | 38034575 | PubTator, text mining | PubMed |
| Role of the redox state of the Pirin-bound cofactor on interaction with the master regulators of inflammation and other pathways. | PLoS One | 2023 | 38033031 | PubTator, text mining | PubMed |
| Troponin and a Myopathy-Linked Mutation in TPM3 Inhibit Cofilin-2-Induced Thin Filament Depolymerization. | Int J Mol Sci | 2023 | 38003645 | PubTator, text mining | PubMed |
| Characterization of a Human Neuronal Culture System for the Study of Cofilin-Actin Rod Pathology. | Biomedicines | 2023 | 38001943 | PubTator, text mining | PubMed |
Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer. | Cancers (Basel) | 2023 | 38001634 | PubTator, text mining | PubMed |
| Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer. | World J Clin Oncol | 2023 | 37970110 | PubTator, text mining | PubMed |
| Role of Actin-Binding Proteins in Skeletal Myogenesis. | Cells | 2023 | 37947600 | PubTator, text mining | PubMed |
| Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. | Cancer Cell Int | 2023 | 37919768 | PubTator, text mining | PubMed |
| Pan-cancer genetic analysis of disulfidptosis-related gene set. | Cancer Genet | 2023 | 37879141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11034/papers?page=4